Loading data
BHSTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 34.51 m USD | 25.19 m USD | 12.67 m USD | 5.5 m USD | 2.1 m USD |
| Cost of revenue | 13.27 m USD | 10.73 m USD | 6.61 m USD | 3.86 m USD | 1.38 m USD |
| Gross profit | 21.24 m USD | 14.46 m USD | 6.06 m USD | 1.64 m USD | 719 k USD |
| Research and development expense | 5.31 m USD | 4.8 m USD | 3.37 m USD | 2.31 m USD | 4.13 m USD |
| Selling, general and administrative expense | 25.19 m USD | 20.2 m USD | 15.18 m USD | 11.54 m USD | 8.82 m USD |
| Operating profit after depreciation | -5.58 m USD | -6.99 m USD | -9.97 m USD | -10.61 m USD | -8.49 m USD |
| Operating profit before depreciation | -3.95 m USD | -5.74 m USD | -9.13 m USD | -9.9 m USD | -8.1 m USD |
| EBIT | -5.58 m USD | -6.99 m USD | -9.97 m USD | -10.61 m USD | -8.49 m USD |
| EBITDA | -3.95 m USD | -5.74 m USD | -9.13 m USD | -9.9 m USD | -8.1 m USD |
| Interest expense | 3.57 m USD | 1.93 m USD | 1.07 m USD | 594 k USD | 852 k USD |
| Profit before tax | -11.06 m USD | -12.91 m USD | -12.56 m USD | -11.24 m USD | -9.83 m USD |
| Income tax expense | 76 k USD | 8 k USD | 0 USD | 0 USD | 0 USD |
| Income before extraordinary items | -11.14 m USD | -12.91 m USD | -12.56 m USD | -11.24 m USD | -9.83 m USD |
| Net income (reported basis) | -11.14 m USD | -12.91 m USD | -12.56 m USD | -11.24 m USD | -9.83 m USD |
| Basic EPS including extraordinary items | -0.6 USD/share | -0.8 USD/share | -0.93 USD/share | -0.02 USD/share | -0.79 USD/share |
| Diluted EPS including extraordinary items | -0.6 USD/share | -0.8 USD/share | -0.93 USD/share | -0.86 USD/share | -0.79 USD/share |
| Common dividends | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Total dividends | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.